Work

963: Ube2n as a Promising New Response Marker to Chemotherapy in Pancreatic Ductal Adenocarcinoma – Results From Mass Spectrometry Analyses of Neoadjuvant Treated Pancreatic Cancer

Year: 2025

Type: article

Source: Gastroenterology

DOI: 10.1016/s0016-5085(25)05413-7

Authors: Lennart von Fritsch, Jannis Duhn, Maren Drenckhan, Lorena Llontop, Cristina Ferrone, Vikram Deshpande, Oliver Schilling, Jutta Kirfel, Rüdiger Braun, Louisa Bolm, Ulrich F. Wellner, Tobias Keck, Kim C. Honselmann

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4412000596

FWCI:

Cites:

Cited by:

Related to: 10